Kailera Therapeutics, Inc. (KLRA)
10.84
-0.49
(-4.32%)
USD |
NASDAQ |
Oct 13, 14:59
Kailera Therapeutics EPS Diluted (Quarterly) : -0.8587 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8587 |
| March 31, 2026 | -0.6087 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.2233 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Twist Bioscience Corp. | -0.5617 |
| Prime Medicine, Inc. | -0.2376 |
| GRAIL, Inc. | -2.557 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -111.31M |
| Total Expenses (Quarterly) | 111.31M |
| Enterprise Value | 562.07M |
| Earnings Yield | -15.60% |